Loiasis: Clinical Trials

3 trials for Loiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Loiasis: new trials by email Literature Review of Loiasis trials Research Report on Loiasis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial Evaluating the Safety and Efficacy of Moxidectin 2 mg Ivermectin-controlled in Loa Loa Microfilaremic Patients
Moxidectin 2 MG Oral Tablet, Ivermectin 3Mg Tab, Placebo oral tablet - Onchocerciasis, Ocular, Loiasis
Phase 2CompletedCenter for Research on Filariasis and Other Tropical Diseases, Cameroon722022-04-072025-02-24
Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients
LEV 1 mg/kg, LEV 1,5 mg/kg, LEV 2,5 mg/kg - Onchocerciasis, Ocular, Loiasis
Phase 2CompletedProgramme National de Lutte contre l'Onchocercose, Republic of the Congo2552021-01-162021-09-20
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
Reslizumab, Diethylcarbamazine, Placebo - Loiasis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)312010-04-012022-01-27

Narrower conditions

Onchocerciasis, Ocular (2)  ·  Filariasis (1)

Broader conditions

Helminthiasis (3)  ·  Infections (3)  ·  Nematode Infections (3)  ·  Parasitic Diseases (3)  ·  Secernentea Infections (3)  ·  Spirurida Infections (3)  ·  Eye Diseases (2)  ·  Eye Infections (2)  ·  Eye Infections, Parasitic (2)  ·  Filariasis (2)  ·  Onchocerciasis (2)  ·  Vector Borne Diseases (2)

Interventions

Diethylcarbamazine (1)  ·  Ivermectin (1)  ·  Levamisole (1)  ·  Tablets (1)  ·  moxidectin (1)  ·  reslizumab (1)

Sponsors

Center for Research on Filariasis and Other Tropical Diseases, Cameroon (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Programme National de Lutte contre l'Onchocercose, Republic of the Congo (1)

Countries

Cameroon (1)  ·  Republic of the Congo (1)  ·  United States (1)

Top investigators

Amy D Klion, M.D. (1)

Results publications

PMID 34651190, PMID 38966851